Development of a prognostic model for acute diarrhea in cervical cancer patients treated with concurrent chemoradiotherapy using Helical Tomotherapy

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

TCTR

Registry ID

TCTR20260610004

Enrollment

217

Registered

2026-06-10

Start date

2021-09-01

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cervical cancer Radiation-induced diarrhea Concurrent Chemoradiotherapy Cervical Cancer, Helical Tomotherapy, Diarrhea, Acute Radiation Toxicity, Concurrent Chemoradiotherapy

Interventions

Cervical cancer patients treated with concurrent chemoradiotherapy using helical tomotherapy who developed acute diarrhea of Grade 2 or higher during radiotherapy, assessed according to CTCAE version

Other,Other

Patients with Grade 2 or higher acute diarrhea,Patients with Grade 0 to 1 acute diarrhea

Eligibility

Sex/Gender

Female

Age

19 Years to 80 Years

Inclusion criteria

Inclusion criteria: Cervical cancer patients treated with concurrent chemoradiotherapy (CCRT) using Helical Tomotherapy

Exclusion criteria

Exclusion criteria: 1. Patients with prior pelvic radiotherapy. 2. Patients who underwent treatment replanning during the radiotherapy course. 3. Patients who received radiotherapy primarily for hemostatic control of active bleeding.

Design outcomes

Primary

Measure	Time frame
Grade 2 or higher acute diarrhea During radiotherapy Occurrence of acute diarrhea of Grade 2 or higher during radiotherapy, assessed according to CTCAE version 5.0	—

Secondary

Measure	Time frame
No secondary outcome Not applicable Not applicable	—

Countries

Thailand

Contacts

Public Contactsuwapim chanlaor

Buddhachinaraj Phitsanulok Hospital

suwapimc67@nu.ac.th055270300

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 10, 2026